Effect of potassium-magnesium citrate on upper gastrointestinal mucosa.

What Was Tested

Researchers studied Glycopyrrolate and Potassium Citrate in this randomized controlled trial publication.

To evaluate the effect of a new potassium supplement, potassium-magnesium citrate (K-Mag), on upper gastrointestinal mucosa and to compare it with an older potassium supplement, potassium citrate (Urocit-K).

Why It Was Studied

Potassium supplements may cause mucosal damage of the gastrointestinal tract.

Who Took Part

According to the abstract, 36 adults were involved.

PubMed indexes the participants as adults, both men and women.

A randomized and double-blind study was conducted utilizing 36 healthy adults.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

Random assignment meant chance, not the researchers, decided who got Glycopyrrolate and who got the comparison, which limits bias.

As a double-blind Glycopyrrolate study, the assignments were hidden from both participants and investigators until the end.

A placebo (an inactive look-alike) gave the Glycopyrrolate group a baseline to be compared against.

On day 8, stool was examined for occult blood, a symptom score was calculated and an oesophagogastroduo-denoscopy was performed.

Mucosal lesions were scored at five anatomic sites.

What Was Measured

Potassium supplements may cause mucosal damage of the gastrointestinal tract.

PubMed files the paper under topics including Citrates, Dietary Supplements, Diuretics, Drug Combinations, Gastric Mucosa, Glycopyrrolate and Intestinal Mucosa.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Glycopyrrolate and Potassium Citrate in 36 adults.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 1998 (Alimentary pharmacology & therapeutics), a journal based in England.

More context: all human trials.